Jasper Therapeutics logo

Jasper Therapeutics Share Price (NASDAQ: JSPR)

$2.8

-0.04

(-1.41%)

Last updated on

Check the interactive Jasper Therapeutics Stock chart to analyse performance

Jasper Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.78
    Today's High:$2.84

    Day's Volatility :2.11%

  • 52 Weeks Low:$2.27
    52 Weeks High:$26.05

    52 Weeks Volatility :91.31%

Jasper Therapeutics Stock Returns

PeriodJasper Therapeutics IncIndex (Russel 2000)
3 Months
-48.53%
0.0%
6 Months
-49.73%
0.0%
1 Year
-85.38%
0.0%
3 Years
-85.04%
-4.1%

Jasper Therapeutics Inc Key Stats

Check Jasper Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.84
Open
$2.84
Today's High
$2.84
Today's Low
$2.78
Market Capitalization
$46.2M
Today's Volume
$94.7K
52 Week High
$26.05
52 Week Low
$2.265
Revenue TTM
$0.0
EBITDA
$-92.7M
Earnings Per Share (EPS)
$-6.05
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-146.87%

Stock Returns calculator for Jasper Therapeutics Stock including INR - Dollar returns

The Jasper Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Jasper Therapeutics investment value today

Current value as on today

₹19,883

Returns

₹80,117

(-80.12%)

Returns from Jasper Therapeutics Stock

₹85,401 (-85.4%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Jasper Therapeutics Stock

-88%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Jasper Therapeutics Stock from India on INDmoney has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Jasper Therapeutics Inc

  • Name

    Holdings %

  • Soleus Capital Management, L.P.

    9.21%

  • Velan Capital Investment Management LP

    8.84%

  • The Carlyle Group Inc

    6.57%

  • Qiming U.S. Ventures Management, LLC

    5.73%

  • BlackRock Inc

    4.86%

  • T. Rowe Price Investment Management,Inc.

    4.34%

Analyst Recommendation on Jasper Therapeutics Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Jasper Therapeutics(by analysts ranked 0 to 5 stars)

Jasper Therapeutics Share Price Target

What analysts predicted

Upside of 600.89%

Target:

$19.63

Current:

$2.80

Jasper Therapeutics share price target is $19.63, a slight Upside of 600.89% compared to current price of $2.80 as per analysts' prediction.

Jasper Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, JSPR stock has moved down by -49.0%
  • JSPR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 157.0%
  • JSPR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 201.2%

Jasper Therapeutics Technicals Summary

Sell

Neutral

Buy

Jasper Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Jasper Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Jasper Therapeutics Inc logo
-2.6%
-49.73%
-85.38%
-85.04%
-97.71%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Jasper Therapeutics Inc

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.
Organization
Jasper Therapeutics
Employees
64
CEO
Mr. Ronald A. Martell
Industry
Miscellaneous

Key Management of Jasper Therapeutics Inc

NameTitle
Mr. Ronald A. Martell
President, CEO & Director
Dr. Judith Anne Shizuru M.D., Ph.D.
Co-Founder, Member of Scientific Advisory Board & Director
Mr. Herbert C. Cross CPA
CFO & Corporate Secretary
Mr. Jeetinder Singh Mahal M.B.A.
Chief Operating Officer
Mr. Matthew Ford
Senior Vice President of Human Resources
Dr. Wendy Pang M.D., Ph.D.
Senior Vice President of Research & Translational Medicine
Dr. Daniel C. Adelman M.D.
Acting Chief Medical Officer, Member of Scientific Advisory Board & Senior Clinical Advisor
Dr. Luca Di Noto Ph.D.
Senior Vice President of Technical Operations
Ms. Patricia Carlos
Senior Vice President of Regulatory Affairs & Quality
Ms. Kimberly Baxter
VP & Head of Quality

Important FAQs about investing in JSPR Stock from India :

What is Jasper Therapeutics share price today?

Jasper Therapeutics share price today is $2.80 as on at the close of the market. Jasper Therapeutics share today touched a day high of $2.84 and a low of $2.78.

What is the 52 week high and 52 week low for Jasper Therapeutics share?

Jasper Therapeutics share touched a 52 week high of $26.05 and a 52 week low of $2.27. Jasper Therapeutics stock price today i.e. is closed at $2.80, lower by 89.25% versus the 52 week high.

How to invest in Jasper Therapeutics Stock (JSPR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Jasper Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jasper Therapeutics Shares that will get you 0.5357 shares as per Jasper Therapeutics share price of $2.80 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Jasper Therapeutics Stock (JSPR) from India?

Indian investors can start investing in Jasper Therapeutics (JSPR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Jasper Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Jasper Therapeutics share’s latest price of $2.80 as on August 30, 2025 at 1:29 am IST, you will get 3.5714 shares of Jasper Therapeutics. Learn more about fractional shares .

What are the returns that Jasper Therapeutics has given to Indian investors in the last 5 years?

Jasper Therapeutics stock has given -97.71% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?